Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

New partnerships aim to expand Teva’s biosimilar portfolio and enhance access to high-cost biologics across key markets.

While the first biosimilars to Soliris have already reached the market in some countries ... for each of its approved indications: paroxysmal nocturnal hemoglobinuria (PNH), atypical haemolytic ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...

Progyny, Inc., a strong player in the fertility benefits market, is undervalued with solid growth potential, making it a good ...

In a report released today, Nick Green from Bernstein maintained a Buy rating on CNH Industrial (CNH – Research Report), with a price target of ...

PNC Financial on Thursday reported a higher fourth-quarter profit as it earned more in interest payments and set aside less ...

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

The Press and Public Relations Coordination of the National Police of Haiti (PNH) announces that this Friday, January 10, 2025 at 9:00 a.m., the graduation ceremony of the 34th promotion of the PNH ...